Effectiveness and safety of rivaroxaban and amlodipine dual therapy compared to phenprocoumon and amlodipine dual therapy in non-valvular atrial fibrillation patients - using German health claims dataFirst published 06/06/2023 Last updated 30/01/2025 EU PAS number: EUPAS105202StudyPlanned